UBS O'Connor’s Thrive Acquisition Corporation Warrant THACW Stock Holding History

UBS O'Connor’s Portfolio THACW Stock Details THACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-73,354	Closed	-$1K	–	869
2022 Q4	$1K	Hold	73,354	–	–	﹤0.01%	752
2022 Q3	$6K	Sell	73,354 -7,344	-9%	-$662	﹤0.01%	933
2022 Q2	$9K	Sell	80,698 -50,557	-39%	-$9.07K	﹤0.01%	947
2022 Q1	$32K	Buy	131,255 +2,313	+2%	+$739	﹤0.01%	923
2021 Q4	$62K	Buy	+128,942	New	+$58.7K	﹤0.01%	890

UBS O'Connor's THACW Position: Q1 2023 in Review

UBS O'Connor sold out of Thrive Acquisition Corporation Warrant (THACW) in Q1 2023, closing a stake of 73,354 shares — an estimated $1K sold.

UBS O'Connor first reported a position in THACW in Q4 2021 and held it in 5 quarters. The position peaked at $62K in Q4 2021. 0 funds tracked by Wall St. Rank hold THACW as of Q1 2023.

UBS O'Connor reported no remaining Thrive Acquisition Corporation Warrant position as of Q1 2023 after selling out during the quarter.
UBS O'Connor sold 73,354 Thrive Acquisition Corporation Warrant shares in Q1 2023, an estimated $1K.
UBS O'Connor first reported a position in Thrive Acquisition Corporation Warrant in Q4 2021 and held it in 5 quarters.
UBS O'Connor's Thrive Acquisition Corporation Warrant position peaked at $62K in Q4 2021.
0 funds tracked by Wall St. Rank held Thrive Acquisition Corporation Warrant as of Q1 2023.

Based on UBS O'Connor's 13F filing for Q1 2023, filed 15 May 2023.